The occurrence of transgelin-2 (TAGLN2) dysregulation [158], which is highly expressed in glioma tissues and closely correlates with prognosis and tumor stage, is known to cause certain malignancies [159]. Here, TAGLN2 is linked to central nervous system cancer.